AI assistant
RESMED INC — Director's Dealing 2017
Aug 21, 2017
30071_dirs_2017-08-21_c55e8379-89f0-4df5-9a3b-3f46ba46efc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-17
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-17 | ResMed Common Stock | A | 7253 | — | Acquired | 85365 | Direct |
| 2017-08-17 | ResMed Common Stock | A | 1443 | — | Acquired | 86808 | Direct |
Footnotes
F1: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2: Represents performance-based restricted stock units granted on June 1, 2017. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.